Literature DB >> 19349106

Thermodynamic approach to oxygen delivery in vivo by natural and artificial oxygen carriers.

Enrico Bucci1.   

Abstract

Oxygen is a toxic gas, still indispensable to aerobic life. This paper explores how normal physiology uses the physico-chemical and thermodynamic characteristics of oxygen for transforming a toxic gas into a non toxic indispensable metabolite. Plasma oxygen concentration is in the range of 10(-5) M, insufficient to sustain metabolism. Oxygen carriers, present in blood, release oxygen into plasma, thereby replacing consumed oxygen and buffering PO(2) near their P(50). They are the natural cell-bound carriers, like hemoglobin inside red cells, myoglobin inside myocytes, and artificial cell-free hemoglobin-based oxygen carriers (HBOC) dissolved in plasma. Metabolic oxygen replacement can be defined as cell-bound and cell-free delivery. Cell-bound delivery is retarded by the slow diffusion of oxygen in plasma and interstitial fluids. The 40% hematocrit of normal blood compensates for the delay, coping with the fast oxygen consumption by mitochondria. Facilitated oxygen diffusion by HBOCs corrects for the slow diffusion, making cell-free delivery relatively independent from P(50). At all oxygen affinities, HBOCs produce hyperoxygenations that are compensated by vasoconstrictions. There is a strict direct correlation between the rate of oxygen replacement and hemoglobin content of blood. The free energy loss of the gradient adds a relevant regulation of tissues oxygenation. Oxygen is retained intravascularly by the limited permeability to gases of vessel walls.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19349106     DOI: 10.1016/j.bpc.2008.12.009

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  2 in total

1.  Free energy changes and components implicit in the MWC allosteric model for the cooperative oxygen binding of hemoglobin.

Authors:  Enrico Bucci; Stefania Pucciarelli; Mauro Angeletti
Journal:  Biochemistry       Date:  2013-06-10       Impact factor: 3.162

2.  Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia.

Authors:  Jiejie Liu; Haojie Hao; Lei Xia; Dongdong Ti; Hong Huang; Liang Dong; Chuan Tong; Qian Hou; Yali Zhao; Huiling Liu; Xiaobing Fu; Weidong Han
Journal:  PLoS One       Date:  2015-05-21       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.